Business Wars cover image

Vaccine Wars | The Hype Cycle | 2

Business Wars

00:00

Navigating the Highs and Lows of the mRNA Market

This chapter examines Moderna's challenges in the competitive mRNA market, emphasizing the impact of their IPO and subsequent stock price decline. It contrasts these difficulties with BioNTech's experience, showcasing the skepticism surrounding mRNA viability amid investor pressure for quick returns.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app